MRI

Latest News


CME Content


A formidably named bit of technology can open a new window into pancreas function, according to a new study in the journal Radiology. Serial magnetic resonance cholangiopancreatography (MRCP) with a spatially selective inversion-recovery (IR) pulse can provide insights into pancreatic flow noninvasively, Japanese researchers reported.

A 57-year-old female presents to the emergency department with dysphagia and reports her throat is “closing up.” On physical exam, there are no palpable masses appreciated along the neck, and the thyroid descends along the midline on swallowing and is noted to be slightly enlarged.

Magnetic resonance imaging (MRI) with 7-Tesla ultrahigh-field-strength technology captures scar tissue and other abnormalities of patients with epilepsy, according to a study published online in the journal Radiology.

Patients with mild traumatic brain injury (MTBI) exhibit abnormal functional connectivity in the thalamus, a relay station for transmitting information throughout the brain, according to a new fMRI study published online in the journal Radiology. The findings could have implications for treatment strategies.

Magnetic resonance enterography should be the imaging method of choice for radiologists diagnosing children with inflammatory bowel diseases, a new study published online in the American Journal of Roentgenology argues.

On February 8, 2011, a new cardiac pacemaker received approval from the FDA, which for the first time allows MRI procedures to be performed in patients by following specific labeling requirements. http://www.medtronic.com/mrisurescan. The “MR Conditional” Revo MRI SureScan Pacing System from Minneapolis-based Medtronic Inc. was designed to minimize the potential interactions with the electromagnetic fields used during MRI examinations.

Magnetic resonance imaging (MRI) and histological biopsy analysis are both efficient methods for subtyping hepatocellular adenomas (HCAs), according to a study published online Jan. 12 in Hepatology.

With Siemens close on its heels, Philips became the first company to get the green light to market its hybrid whole body PET/MR imaging system. Royal Philips Electronics announced this week that it received a CE marking, allowing the company to begin selling in Europe.

Magnetic resonance imaging (MRI) can be used to monitor response during neoadjuvant chemotherapy (NAC), and it is effective in triple-negative or human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to a study published online Jan. 10 in the Journal of Clinical Oncology.

PET/MR is the logical next step in hybridization, the step that follows PET/CT, one that vendors finally took at this year's RSNA meeting. It has come a decade after PET/CT was first commercialized and nearly as long since pundits concluded that its arrival was inevitable.